Literature DB >> 16651322

Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome.

Enrico Zecca1, Daniele De Luca, Marco Marras, Alessandro Caruso, Tommaso Bernardini, Costantino Romagnoli.   

Abstract

OBJECTIVES: We sought to verify the association between maternal intrahepatic cholestasis of pregnancy (ICP) and neonatal respiratory distress syndrome (RDS) and to determine how bile acids levels alter the risk of developing neonatal RDS.
METHODS: We extracted data from our divisional database about all of the newborns born during the years 2000-2004. We compared 77 neonates born from pregnancies complicated by ICP with 427 neonates in the same range of gestational age born from noncomplicated pregnancies. We studied maternal bile acids levels immediately before delivery in mothers with ICP and measured bile acid levels during the first 24 hours of life in their newborns.
RESULTS: The incidence of RDS in newborns from cholestatic pregnancies was twice that the reference population (28.6% vs 14%). The multivariate analysis showed that the risk of RDS in these newborns was approximately 2.5 times higher than in control infants. Within the ICP group, maternal and neonatal bile acid levels of infants affected by RDS were not significantly higher than those of healthy infants. The multivariate analysis showed that a low gestational age was the most important risk factor, but the probability of respiratory distress syndrome also increased by 2 per thousand for every additional micromole of the interaction term "neonatal by maternal bile acids level."
CONCLUSIONS: Maternal ICP is significantly associated with the occurrence of RDS in the newborn. We hypothesize that bile acids can produce surfactant depletion in the alveoli reverting the reaction of phospholipase A2. This hypothesis could potentially be confirmed by bronchoalveolar lavage study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651322     DOI: 10.1542/peds.2005-1801

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

Review 1.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

Review 2.  Bile acids regulate cardiovascular function.

Authors:  Sandeep Khurana; Jean-Pierre Raufman; Thomas L Pallone
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

Review 3.  Interventions for treating cholestasis in pregnancy.

Authors:  Vinita Gurung; Philippa Middleton; Stephen J Milan; William Hague; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

4.  Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.

Authors:  Tetsuya Kawakita; Laura I Parikh; Patrick S Ramsey; Chun-Chih Huang; Alexander Zeymo; Miguel Fernandez; Samuel Smith; Sara N Iqbal
Journal:  Am J Obstet Gynecol       Date:  2015-06-10       Impact factor: 8.661

5.  Role of macrophages in bile acid-induced inflammatory response of fetal lung during maternal cholestasis.

Authors:  Elisa Herraez; Elisa Lozano; Evelyn Poli; Verena Keitel; Daniele De Luca; Catherine Williamson; Jose J G Marin; Rocio I R Macias
Journal:  J Mol Med (Berl)       Date:  2013-12-07       Impact factor: 4.599

6.  Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

Authors:  Daniele De Luca; Angelo Minucci; Enrico Zecca; Marco Piastra; Domenico Pietrini; Virgilio P Carnielli; Cecilia Zuppi; Ascanio Tridente; Giorgio Conti; Ettore D Capoluongo
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

7.  Intrahepatic cholestasis of pregnancy: biochemical predictors of adverse perinatal outcomes.

Authors:  Hui Chen; Yuan Zhou; Dong-Rui Deng; Hai-Yan Hao; Jing Dang; Jing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

Review 8.  Pregnancy-associated liver disorders.

Authors:  Iryna S Hepburn; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-02-07       Impact factor: 3.199

9.  Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.

Authors:  Lucy C Chappell; Vinita Gurung; Paul T Seed; Jenny Chambers; Catherine Williamson; James G Thornton
Journal:  BMJ       Date:  2012-06-13

10.  Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study.

Authors:  Daniele De Luca; Ettore Capoluongo; Vincent Rigo
Journal:  BMC Pediatr       Date:  2011-11-08       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.